K2 HealthVentures Equity Trust LLC - 31 Dec 2024 SCHEDULE 13G/A Report for TScan Therapeutics, Inc. Voting Common Stock, $0.0001 par value per share (TCRX)

Filing Manager
K2 HealthVentures Equity Trust LLC
Reporting Manager
K2 HealthVentures Equity Trust LLC
Security
TScan Therapeutics, Inc. Voting Common Stock, $0.0001 par value per share
Symbol
TCRX
Shares outstanding
52,213,043 shares
Disclosed Ownership
3,602,700 shares
Ownership
6.9%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 16:33:04 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"K2 HealthVentures Equity Trust LLC disclosed 6.9% ownership in TScan Therapeutics, Inc. Voting Common Stock, $0.0001 par value per share (TCRX) on 31 Dec 2024."

Quick Takeaways

  • K2 HealthVentures Equity Trust LLC filed SCHEDULE 13G/A for TScan Therapeutics, Inc. Voting Common Stock, $0.0001 par value per share (TCRX).
  • Disclosed ownership: 6.9%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Feb 2025, 16:33.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
K2 HealthVentures Equity Trust LLC 6.9% 3,602,700 0 3,602,700 /s/ Anup Arora Anup Arora, Managing Member
Parag Shah 6.9% 3,602,700 0 3,602,700 /s/ Parag Shah Parag Shah
Anup Arora 6.9% 3,602,700 0 3,602,700 /s/ Anup Arora Anup Arora

Sponsored